NAD+ Therapy in Houston — What It Is, Who It’s For, How It

NAD+ Therapy in Houston — What It Is, Who It's For, How It Works

The average adult loses approximately 50% of cellular NAD+ by age 50 compared to age 20. A decline linked to mitochondrial dysfunction, impaired DNA repair, and accelerated biological aging according to research published by Harvard Medical School in 2023. For Houston residents navigating weight loss plateaus, post-GLP-1 metabolic recovery, or chronic fatigue that doesn't resolve through standard interventions, NAD+ therapy has become a medically supervised option. But it's not a quick fix, and not every patient needs it.

Our team has worked with patients transitioning off semaglutide and tirzepatide who report persistent fatigue, brain fog, or metabolic sluggishness even after successful weight loss. NAD+ therapy addresses a specific cellular deficiency. It doesn't replace healthy metabolism, but in the right context, it supports the machinery that makes metabolism work.

What is NAD+ therapy, and why does it matter for metabolic health?

NAD+ therapy involves intravenous infusion or intramuscular injection of nicotinamide adenine dinucleotide, a coenzyme required for mitochondrial energy production, DNA repair via PARP enzymes, and activation of sirtuins. Proteins that regulate cellular aging. Unlike oral NAD+ supplements, which are largely degraded in the digestive tract, IV and IM administration deliver the coenzyme directly into systemic circulation. Clinical applications include metabolic recovery after significant weight loss, neuroprotection during addiction recovery, and cellular resilience support in aging populations.

NAD+ isn't a weight loss medication. It's cellular infrastructure. If you've lost 40 pounds on tirzepatide but still feel metabolically flat, it's worth understanding what NAD+ does and whether Houston providers offer evidence-based protocols. This piece covers the biological mechanism, who genuinely benefits, the difference between IV and IM delivery, what preparation mistakes negate the effect entirely, and what the evidence actually shows versus what wellness marketing claims.

What NAD+ Actually Does in the Body — and Why It Declines

NAD+ functions as an electron carrier in cellular respiration. Specifically, it accepts electrons during glycolysis and the citric acid cycle, then delivers them to the mitochondrial electron transport chain where ATP is synthesised. Without sufficient NAD+, mitochondria can't efficiently convert glucose and fatty acids into usable energy. This isn't theoretical. NAD+ levels decrease with age, chronic metabolic stress, alcohol use, and caloric restriction (including intentional weight loss), which is why patients sometimes report fatigue even after achieving goal weight.

Beyond energy production, NAD+ activates sirtuins (SIRT1 through SIRT7), a family of proteins that regulate DNA repair, inflammation, and mitochondrial biogenesis. These enzymes require NAD+ as a cofactor. When NAD+ is depleted, sirtuin activity drops, which accelerates cellular aging markers like telomere shortening and oxidative damage. Research from Washington University School of Medicine found that boosting NAD+ in aged mice restored mitochondrial function to levels comparable to young mice. The mechanism is real, even if human clinical translation is still being mapped.

NAD+ also powers PARP enzymes (poly ADP-ribose polymerases), which repair single-strand DNA breaks caused by oxidative stress, UV exposure, and normal metabolic byproducts. When cells are under high oxidative load. During rapid weight loss, intense exercise, or metabolic disease. PARP activity increases, consuming NAD+ faster than the body can synthesise it through salvage pathways (the primary route being conversion of nicotinamide via NAMPT enzyme). This depletion creates a deficit that oral supplements struggle to address because NAD+ molecules are too large to cross cell membranes intact.

Who Benefits from NAD+ Therapy — and Who Doesn't

NAD+ therapy isn't a universal intervention. It's clinically indicated for patients experiencing symptoms tied to cellular energy deficits that haven't resolved through standard metabolic support. The clearest use cases include metabolic recovery after significant weight loss (especially post-GLP-1 therapy), addiction recovery protocols where neuronal NAD+ is depleted, chronic fatigue syndrome with documented mitochondrial dysfunction, and neuroprotection strategies in neurodegenerative conditions like Parkinson's disease.

Patients transitioning off semaglutide or tirzepatide sometimes report persistent brain fog, low energy, and metabolic sluggishness even after successful weight loss. This isn't medication withdrawal, it's metabolic recalibration. GLP-1 agonists improve insulin sensitivity and reduce caloric intake, but they don't directly restore NAD+ pools depleted during months of caloric deficit. For these patients, a 4–6 week NAD+ protocol (500–1000mg IV weekly) can support mitochondrial recovery while dietary habits stabilise.

Who doesn't benefit? Patients expecting NAD+ to function as a weight loss agent, metabolism booster, or anti-aging cure. NAD+ won't burn fat, suppress appetite, or reverse decades of cellular damage in a single infusion. It's infrastructure repair, not metabolic intervention. If you're metabolically healthy, sleeping well, and eating adequately, your endogenous NAD+ synthesis is likely sufficient. Adding exogenous NAD+ in that context is like pouring premium fuel into a full tank. It doesn't improve performance because the system isn't limiting.

IV vs IM Delivery — Which Route Works and Why

NAD+ therapy is delivered via intravenous infusion (250–1000mg over 2–4 hours) or intramuscular injection (100–200mg per dose). IV delivery achieves higher peak plasma concentrations and faster cellular uptake, making it the preferred route for acute interventions like addiction recovery or post-surgery metabolic support. IM delivery produces lower peak levels but sustained release over 24–48 hours, which some patients tolerate better and find more practical for maintenance protocols.

The primary limitation of IV NAD+ is infusion-related side effects. Nausea, chest tightness, and transient anxiety occur in 30–40% of patients during rapid infusion, caused by histamine release and vasodilation. Slowing the infusion rate to 4+ hours and pre-medicating with magnesium glycinate (400mg) significantly reduces these effects. IM NAD+ bypasses the infusion reaction but requires multiple injection sites (deltoid or vastus lateralis) due to volume limits per site. 1–2mL maximum to avoid muscle soreness.

Oral NAD+ precursors (nicotinamide riboside, nicotinamide mononucleotide) are marketed as alternatives, but their bioavailability is contested. A 2023 study in Nature Metabolism found that oral NMN does increase circulating NAD+ metabolites, but whether this translates to functional intracellular NAD+ increases in human tissues remains unclear. For patients seeking measurable clinical outcomes. Energy restoration, cognitive clarity, metabolic resilience. IV or IM delivery currently offers the most direct route.

NAD+ Therapy in Houston: Medical vs Wellness Protocols

Key Takeaways

• NAD+ is a coenzyme required for mitochondrial ATP production, DNA repair via PARP enzymes, and sirtuin activation. Cellular NAD+ levels decline approximately 50% between ages 20 and 50.
• IV NAD+ therapy (500–1000mg per session over 2–4 hours) delivers the highest bioavailability but requires clinical supervision due to infusion-related side effects including nausea and chest tightness in 30–40% of patients.
• Patients transitioning off GLP-1 medications who report persistent fatigue or brain fog may benefit from a 4–6 week NAD+ protocol as part of metabolic recovery. It's cellular infrastructure repair, not a metabolism booster.
• Oral NAD+ precursors like NMN and NR increase circulating metabolites but lack conclusive evidence of functional intracellular NAD+ elevation in human tissues. IV or IM delivery remains the most direct route for measurable outcomes.
• NAD+ therapy is clinically indicated for metabolic recovery, addiction protocols, and neuroprotection. Not for weight loss, anti-aging miracles, or patients without documented cellular energy deficits.

What If: NAD+ Therapy Scenarios

What If I Feel Worse After My First NAD+ Infusion?

Reduce the infusion rate immediately and consider pre-medication with magnesium glycinate (400mg) 30 minutes before the next session. The chest tightness, nausea, and anxiety some patients experience are caused by histamine release and vasodilation. They're uncomfortable but not dangerous. Slowing the drip from 2 hours to 4 hours resolves the reaction in most cases. If symptoms persist despite rate adjustment, switch to IM delivery or split the dose across two sessions per week at lower mg per infusion.

What If I Don't Notice Any Energy Improvement After 4 Weeks?

NAD+ therapy addresses cellular energy deficits. If your fatigue is caused by sleep apnea, thyroid dysfunction, or anemia, exogenous NAD+ won't resolve it. Before continuing therapy, verify baseline labs including TSH, ferritin, B12, and metabolic panel. If those are normal and mitochondrial dysfunction is suspected, consider pairing NAD+ with CoQ10 (200mg ubiquinol daily) and L-carnitine (1000mg), which support electron transport chain function. If there's still no subjective or objective improvement after 8 sessions, NAD+ deficiency likely isn't the limiting factor.

What If I Want to Start NAD+ While Still on Tirzepatide?

There's no pharmacological interaction between GLP-1 agonists and NAD+ therapy. They work through entirely separate mechanisms. Starting NAD+ during active weight loss may support mitochondrial function during caloric restriction, but it won't accelerate fat loss or enhance GLP-1 efficacy. The stronger clinical rationale is waiting until after you've reached maintenance weight, then using NAD+ to support metabolic recovery if fatigue persists despite stable eating and adequate sleep.

The Blunt Truth About NAD+ Therapy

Here's the honest answer: NAD+ therapy works for a specific subset of patients with genuine cellular energy deficits, and it's wildly oversold to everyone else. The wellness industry markets it as an anti-aging cure, a metabolism fix, and a cognitive enhancer. Claims that far exceed the clinical evidence. NAD+ is real science applied to real deficiencies, but it's not a universal upgrade. If your mitochondria are functioning normally, adding more NAD+ is like adding oil to an engine that's already full. It doesn't improve performance.

The patients who benefit most are those transitioning off intensive metabolic interventions (like GLP-1 therapy), recovering from addiction where neuronal NAD+ is depleted, or managing documented mitochondrial dysfunction. For everyone else, the money spent on IV NAD+ would generate better health returns invested in sleep optimization, resistance training, and dietary protein adequacy. We've worked with hundreds of patients in this space. The ones who see meaningful results from NAD+ are the ones who had a real deficit to correct, not the ones chasing longevity hacks.

The biggest mistake people make with NAD+ therapy isn't the infusion. It's expecting it to compensate for poor foundational health. If you're sleeping 5 hours, eating 80g protein daily, and skipping resistance training, NAD+ won't fix what discipline would. The coenzyme supports cellular machinery that's already working. It doesn't replace the machinery itself.

For Houston residents considering NAD+ therapy post-GLP-1 treatment, the practical path forward is this: stabilise your weight and metabolic habits first, then assess whether fatigue persists despite adequate sleep, nutrition, and recovery. If it does, a 4–6 week NAD+ trial (IV or IM, dosed correctly, through a licensed provider) is a reasonable intervention. If fatigue resolves with better sleep hygiene and protein intake, you've saved yourself $2000 and identified the actual bottleneck. NAD+ is cellular infrastructure. Build the foundation first, then reinforce the structure if needed.

Start Your Treatment Now if you're ready to work with licensed providers who prescribe based on clinical need, not wellness trends. TrimRx offers medically supervised GLP-1 therapy and metabolic recovery support. Consultation available to any patient looking for evidence-based weight management and post-treatment optimization.